Angiogenesis and its therapeutic implication. 3. Molecular mechanisms of retinal neovascularization in diabetic retinopathy

Internal Medicine

Volumn 42, Issue 3, 2003, Pages 299-301

  Takagi, Hitoshi ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiogenesis; Angiopoietin; Diabetic retinopathy; Vascular endothelial growth factor

Indexed keywords

ANGIOPOIETIN; ANGIOPOIETIN 1; ANGIOPOIETIN 2; ANGIOTENSIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYBRID PROTEIN; NEUROPILIN 1; PEGAPTANIB; PROTEIN KINASE B; PROTEIN KINASE INHIBITOR; SEMAXANIB; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 2; VASCULOTROPIN TRAP; VEGF TRAP; ANGIOGENIC FACTOR; ENDOTHELIAL CELL GROWTH FACTOR; LYMPHOKINE; SIGNAL PEPTIDE; VASCULOTROPIN A;

BLOOD VESSEL PERMEABILITY; CELL COMMUNICATION; CLINICAL TRIAL; CONFERENCE PAPER; DIABETIC RETINOPATHY; DISEASE SEVERITY; DRUG MECHANISM; ENDOTHELIUM CELL; HUMAN; HYPOXIA; MOLECULAR BIOLOGY; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RETINA ISCHEMIA; RETINA MACULA EDEMA; RETINA NEOVASCULARIZATION; SIGNAL TRANSDUCTION; UPREGULATION; ARTICLE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANGIOGENESIS INDUCING AGENTS; DIABETIC RETINOPATHY; ENDOTHELIAL GROWTH FACTORS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOKINES; NEUROPILIN-1; RETINAL NEOVASCULARIZATION; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0038673701     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.42.299     Document Type: Conference Paper

References (10)

1. Aiello LP, Avery RL, Arrigg PG, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. [see comments] N Engl J Med 331: 1480-1487, 1994.
2. Oh H, Takagi H, Suzuma K, Otani A, Matsumura M, Honda Y. Hypoxia and vascular endothelial growth factor selectively up-regulate angiopoietin-2 in bovine microvascular endothelial cells. J Biol Chem 274: 15732-15739, 1999.
3. Antonelli-Orlidge A, Saunders KB, Smith SR, D'Amore PA. An activated form of transforming growth factor beta is produced by cocultures of endothelial cells and pericytes. Proc Natl Acad Sci USA 86: 4544-4548, 1989.
4. Takagi H, King GL, Aiello LP. Identification and characterization of vascular endothelial growth factor receptor (Flt) in bovine retinal pericytes. Diabetes 45: 1016-1023, 1996.
5. Takagi H, Koyama S, Seike H, et al. Potential role of angiopoietin/Tie2 system in ischemia-induced retinal neovascularization. Invest Ophthalmol Vis Sci 44: 393-402, 2003.
6. Oh H, Takagi H, Otani A, et al. Selective induction of neuropilin-1 by vascular endothelial growth factor (VEGF): A mechanism contributing to VEGF-induced angiogenesis. Proc Natl Acad Sci USA 99: 383-388 2002.
7. Chaturvedi N, Sjolie AK, Stephenson JM, et al. Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. The EUCLID Study Group. EURODIAB Controlled Trial of Lisinopril in Insulin-Dependent Diabetes Mellitus. Lancet 351: 28-31, 1998.
8. Otani A, Takagi H, Suzuma K, Honda Y. Angiotensin II potentiates vascular endothelial growth factor-induced angiogenic activity in retinal microcapillary endothelial cells. Circ Res 82: 619-628, 1998.
9. Otani A, Takagi H, Oh H, Koyama S, Honda Y. Angiotensin II induces expression of Tie receptor ligand angiopoieitin 2 in bovine retinal endothelial cells. Diabetes 50: 867-875, 2001.
10. Ishii H, Jirousek MR, Koya D, et al. Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor. [see comments] Science 272: 728-731, 1996.